Quarterly report · Q2
3055.TEDINET S100PK8H
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥129.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥248.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥122.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥759m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥140.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥136.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥137.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥83.9bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥81.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥56.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥55.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥55.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥21.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.6bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥122m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥224m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥633m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥849m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥648m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥62.94 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.44 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.06 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.17 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.3% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥1.6bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥30m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1.6bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥910m |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6m |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥40m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥848m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥217m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥631m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥20m |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥33.0bn |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥32.7bn |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥251m |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥777m |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1m |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥172m |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥92.3bn |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥87.7bn |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥347m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥136.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥129.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥2.2bn |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥1.0bn |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥30m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥991m |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥345m |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥7m |
| jpcrp040300-q2r_E03003-000Dispensing Industryreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥40m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥675m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥217m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥457m |
| jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥28m |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥30.7bn |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥30.4bn |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥237m |
| jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥572m |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥5m |
| jpcrp040300-q2r_E03003-000Nursing Industryreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥157m |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥87.2bn |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥82.8bn |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥128.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥122.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 550
| Item | Context | Value | Unit |
|---|---|---|---|
| Allowance for doubtful accounts ca | Prior1YearInstant | -20000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -13000000 | JPY |
| Current assets | Prior1YearInstant | 97495000000 | JPY |
| Current assets | CurrentQuarterInstant | 101157000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 7844000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 9563000000 | JPY |
| Land | Prior1YearInstant | 9421000000 | JPY |
| Land | CurrentQuarterInstant | 9475000000 | JPY |
| Construction in progress | Prior1YearInstant | 2301000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 334000000 | JPY |
| Other net ppe | Prior1YearInstant | 852000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 868000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 20420000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 20241000000 | JPY |
| Goodwill | Prior1YearInstant | 1069000000 | JPY |
| Goodwill | CurrentQuarterInstant | 1014000000 | JPY |
| Software | Prior1YearInstant | 541000000 | JPY |
| Software | CurrentQuarterInstant | 473000000 | JPY |
| Other ia | Prior1YearInstant | 186000000 | JPY |
| Other ia | CurrentQuarterInstant | 280000000 | JPY |
| Intangible assets | Prior1YearInstant | 1797000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 1769000000 | JPY |
| Investment securities | Prior1YearInstant | 15475000000 | JPY |
| Investment securities | CurrentQuarterInstant | 15846000000 | JPY |
| Long term accounts receivable ioa | Prior1YearInstant | 109000000 | JPY |
| Long term accounts receivable ioa | CurrentQuarterInstant | 104000000 | JPY |
| Long term loans receivable | Prior1YearInstant | 393000000 | JPY |
| Long term loans receivable | CurrentQuarterInstant | 350000000 | JPY |
| Deferred tax assets | Prior1YearInstant | 574000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 507000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 1000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 2000000 | JPY |
| Other ioa | Prior1YearInstant | 738000000 | JPY |
| Other ioa | CurrentQuarterInstant | 719000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -123000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -111000000 | JPY |
| Investments and other assets | Prior1YearInstant | 17170000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 17418000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 39388000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 39429000000 | JPY |
| Assets | Prior1YearInstant | 136883000000 | JPY |
| Assets | CurrentQuarterInstant | 140586000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 71627000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 74391000000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 2231000000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 2565000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 1000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 1000000 | JPY |
| Income taxes payable | Prior1YearInstant | 885000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 801000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |